Stephen J. McAndrew
Chief Business Officer · Sonnet BioTherapeutics Holdings, Inc.
Individual
- 2025
- Dec 3, 2025
- 2
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Stephen J. McAndrew's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- BVF PARTNERS L P - $62.96M in MLTX purchases and sales in the last 12 months
- Mario Schlosser - $62.90M in OSCR purchases and sales in the last 12 months
- BROADWOOD PARTNERS, L.P. - $62.75M in STAA purchases and sales in the last 12 months
- Jonathan M. Rothberg - $62.19M in BFLY purchases and sales in the last 12 months
- Jeffrey M. Leiden - $60.94M in VRTX purchases and sales in the last 12 months
- Dinesh V. Ph D. Patel - $60.58M in PTGX purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stephen J. McAndrew?
Stephen J. McAndrew is a corporate insider, tracked as Chief Business Officer of Sonnet BioTherapeutics Holdings, Inc. (SONN). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Stephen J. McAndrew last file a Form 4?
The most recent primary Form 4 on record is dated 3 December 2025, one of 2 filings going back to 2025.
